Paul Ehrlich

Verified Timeline

Lore & Background

Paul Ehrlich was a German physician and scientist whose work spanned hematology, immunology, and antimicrobial chemotherapy. He shared the 1908 Nobel Prize in Physiology or Medicine for his contributions to immunity. Among his most notable achievements was the discovery of a cure for syphilis in 1909, as well as a key modification to the Gram staining technique for bacteria. His methods for staining tissue allowed differentiation between blood cell types, enabling the diagnosis of numerous blood diseases. Ehrlich’s laboratory developed arsphenamine, the first antimicrobial drug and first effective treatment for syphilis, and he coined the term “chemotherapy.” He introduced the concept of a “magic bullet” and contributed to the development of a diphtheria antiserum and a method for standardizing therapeutic serums. He was the founder and first director of what became the Paul Ehrlich Institute, Germany’s federal institute for vaccines and biomedicines. The bacterial genus *Ehrlichia* is named after him, and he is often called the “father of immunology.” Ehrlich was born in Strehlen, Silesia, to a Jewish family; his father was an innkeeper and lottery collector. He studied medicine in Breslau, Strasbourg, and Freiburg, earning his doctorate in Leipzig. After working at the Charité in Berlin, he contracted tuberculosis in the laboratory and traveled to Egypt and other countries in 1888–1889 to recover. He later worked with Robert Koch and directed institutes for serum research and experimental therapy in Berlin and Frankfurt. In 1914, Ehrlich signed the Manifesto of the Ninety-Three, defending Germany’s World War I policies. He died of a heart attack in 1915.

Reader's Guide

Paul Ehrlich's significance lies in his foundational contributions to multiple medical fields. He shared the 1908 Nobel Prize for work on immunity, but his most celebrated achievement was the 1909 discovery of Salvarsan, the first targeted antimicrobial drug, which initiated the concept of chemotherapy. He also introduced the idea of a 'magic bullet'—a drug that selectively targets a pathogen. In hematology, his staining techniques allowed differentiation of white blood cells and identification of red blood cell precursors, enabling diagnosis of blood diseases. He developed a method for standardizing therapeutic serums and contributed to an antiserum for diphtheria. His modification of Gram staining remains a standard technique. The bacterial genus Ehrlichia is named after him. His work bridged chemistry, biology, and medicine, though it initially faced resistance from the medical establishment. His legacy endures in modern chemotherapy, immunology, and diagnostic hematology.

Did You Know?

• Ehrlich discovered mast cells, naming them from the German word for animal-fattening feed, Mast.
• He developed a dry specimen technique for staining blood cells using a Bunsen burner.
• His laboratory discovered Salvarsan, the first antimicrobial drug, in 1909.
• The Paul Ehrlich Institute was renamed in his honor in 1947.